These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37311359)

  • 21. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
    Ren X; Wang W; Cao H; Shao F
    Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney failure risk in type 1 vs. type 2 childhood-onset diabetes mellitus.
    Pleniceanu O; Twig G; Tzur D; Gruber N; Stern-Zimmer M; Afek A; Erlich T; Keinan-Boker L; Skorecki K; Calderon-Margalit R; Vivante A
    Pediatr Nephrol; 2021 Feb; 36(2):333-340. PubMed ID: 32761484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-Onset Type 2 Diabetes as a Risk Factor for End-Stage Renal Disease in Patients With Diabetic Kidney Disease.
    Zheng L; Chen X; Luo T; Ran X; Hu J; Cheng Q; Yang S; Wu J; Li Q; Wang Z
    Prev Chronic Dis; 2020 Jul; 17():E50. PubMed ID: 32614772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of
    Cheng Y; Liu Y; Lin L; Li D; Peng L; Zheng K; Tao J; Li M
    Ren Fail; 2024 Dec; 46(1):2295425. PubMed ID: 38178377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
    Zhao B; Zhang M; Xie J; Jiang T; Li J; Yang Z
    Int Immunopharmacol; 2022 Aug; 109():108916. PubMed ID: 35679662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease.
    Xiao X; Zhang J; Ji S; Qin C; Wu Y; Zou Y; Yang J; Zhao Y; Yang Q; Liu F
    Front Endocrinol (Lausanne); 2022; 13():1026995. PubMed ID: 36277729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
    Sasso FC; Pafundi PC; Gelso A; Bono V; Costagliola C; Marfella R; Sardu C; Rinaldi L; Galiero R; Acierno C; Caturano A; de Sio C; De Nicola L; Salvatore T; Nevola R; Adinolfi LE; Minutolo R;
    Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):923-930. PubMed ID: 31377186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between gain in adiposity and diabetic kidney disease worsening in type 2 diabetes is mediated by deteriorating glycaemic control: A 3-year follow-up analysis.
    Moh AMC; Wang J; Tan C; Ang SF; Ang K; Subramaniam T; Sum CF; Kwan PY; Lee SBM; Tang WE; Lim SC
    Diabetes Res Clin Pract; 2019 Nov; 157():107812. PubMed ID: 31401149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease.
    Duan S; Sun L; Zhang C; Wu L; Nie G; Huang Z; Xing C; Zhang B; Yuan Y
    Int Immunopharmacol; 2021 Apr; 93():107413. PubMed ID: 33524800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.
    Niu J; Zhang X; Li M; Wu S; Zheng R; Chen L; Huo Y; Xu M; Wang T; Zhao Z; Wang S; Lin H; Qin G; Yan L; Wan Q; Chen L; Shi L; Hu R; Tang X; Su Q; Yu X; Qin Y; Chen G; Gao Z; Wang G; Shen F; Luo Z; Chen Y; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Li Q; Mu Y; Zhao J; Bi Y; Ning G; Wang W; Lu J; Xu Y;
    Diabetes Metab; 2023 Mar; 49(2):101420. PubMed ID: 36640827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of and risk factors for normoalbuminuric diabetic kidney disease in hospitalized patients with type 2 diabetes mellitus: a retrospective cross-sectional study.
    Dai Q; Chen N; Zeng L; Lin XJ; Jiang FX; Zhuang XJ; Lu ZY
    BMC Endocr Disord; 2021 May; 21(1):104. PubMed ID: 34022855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors associated with the development of diabetic kidney disease in Sudanese patients with type 2 diabetes mellitus: A case-control study.
    Shigidi MM; Karrar WN
    Diabetes Metab Syndr; 2021; 15(6):102320. PubMed ID: 34700293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of noninvasive lens advanced glycation end product detection in early screening and severity evaluation of patients with diabetic kidney disease.
    Zheng X; Gao Y; Huang Y; Dong R; Yang M; Zhang X; Zeng M; Zhang R; Wu Y; Yu Z; Liu J; Zha B
    BMC Nephrol; 2023 Dec; 24(1):379. PubMed ID: 38115082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rs3931283/PVT1 and rs7158663/MEG3 polymorphisms are associated with diabetic kidney disease and markers of renal function in patients with type 2 diabetes mellitus.
    Dieter C; Lemos NE; Girardi E; Ramos DT; Pellenz FM; Canani LH; Assmann TS; Crispim D
    Mol Biol Rep; 2023 Mar; 50(3):2159-2169. PubMed ID: 36565414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of Noninvasive Detection of Advanced Glycation End Products in the Lens to Screen for Diabetic Kidney Disease.
    Zhang XM; Gao Y; Yang MX; Zheng XD; Zhang R; Wu YY; Zeng M; Yang Q; Yu ZY; Liu J; Zha BB; Yang B
    Front Endocrinol (Lausanne); 2022; 13():892070. PubMed ID: 35846309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hip Fracture Risk According to Diabetic Kidney Disease Phenotype in a Korean Population.
    Lee SE; Yoo J; Kim KA; Han K; Choi HS
    Endocrinol Metab (Seoul); 2022 Feb; 37(1):148-158. PubMed ID: 35255607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
    Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
    Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of ferroptosis-related biomarkers for diabetic kidney disease: a prospective observational study.
    Wu Y; Sun Y; Wu Y; Zhang K; Chen Y
    Acta Diabetol; 2023 Apr; 60(4):507-516. PubMed ID: 36633709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney biopsy can help to predict renal outcomes of patients with type 2 diabetes mellitus.
    Kim WJ; Oh T; Heo NH; Kwon K; Shin GE; Jeong SH; Lee JH; Park S; Cho NJ; Gil HW; Lee EY
    Kidney Res Clin Pract; 2024 Jan; ():. PubMed ID: 38212871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.